Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CompTIA is a leading global trade association and provider of vendor-neutral IT certifications, serving as a foundational pillar for the digital infrastructure of the healthcare and life sciences industries. While not a drug developer, the organization establishes the professional standards for IT staff who manage electronic health records (EHR), secure clinical data, and ensure HIPAA compliance across the healthcare ecosystem. Its certifications, including Security+ and the specialized Healthcare IT Technician credential, are widely recognized benchmarks for technical competency in medical environments. In early 2025, CompTIA's certification and training business was acquired by private equity firms H.I.G. Capital and Thoma Bravo, transitioning it to a for-profit model. The organization continues to drive workforce development and cybersecurity readiness, which are critical for the secure operation of modern biotech and pharmaceutical enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CompTIA.